TPMT testing in rheumatology: any better than routine monitoring?
Payne
K
K
Newman
W
W
Fargher
E
E
Tricker
K
K
Bruce
I N
IN
Ollier
W E R
WE
D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects*; D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000379:methods*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D008780:Methyltransferases / Q000097:blood*; D012216:Rheumatic Diseases / Q000188:drug therapy / Q000201:enzymology* / Q000235:genetics
D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D008780:Methyltransferases; C022745:thiopurine methyltransferase; D001379:Azathioprine